All Type of News
The 3 reasons why Cialis generics may struggle
Although 150 generic products of 50 pharmaceutical companies will be poured out facing the patent expiration of ‘Cialis(generic name: tadalafil) on September, the ‘spring of impotency treatment,’ happened in 2012, wil...
Despite MERS sales of listed pharmaceutical companies increased 10% up in the 2nd quarter
Despite the Middle East Respiratory Syndrome, which struck Korea in the 2nd quarter of the year, sales of listed pharmaceutical companies are assessed to be decent.
According to the analysis result of sales reports o...
Laboratory Sinfa established a partnership contract with the Boehringer Ingelheim Korea’s OTC departmentLaboratori Sinfa(President Joo-cheol Lee), a Spanish pharmaceutical company, will expand its business into the medical device industry through the strategically partnership cont...
|
.jpg)
Reliability and preference towards generics took a step backwards
It is surveyed that doctors’ reliability and preference towards generic products have not been improved for the past 4 year. Despite effort of domestic pharmaceutical companies and the government to improve images of ...
Will the two biosimilars sold by foreign companies be successful in the domestic market?
Lilly and MSD are expected to introduce biosimilars in the domestic market.
According to the industry concerned on the 18th, Lilly and MSD have turned in approval applications for biosimilars of ‘Lantus(insulin glarg...
The first domestic patent nullity of Humira will stimulate biosimilar development
One of domestic patents of Humira(Abbvie), a TNF-Alpha inhibitor used mainly in rheumatoid arthritis treatment, has been ruled to be nullified.
Thus, biosimilar development of domestic pharmaceutical companies, such ...
The highest benefited pharmaceutical company was ‘Pfizer’ last year, followed by ‘Daewoong’Among the 20 pharmaceutical companies with the highest prescription pharmaceutical products benefited by the National Health Insurance, the top one has been known to be ‘Pfizer ...
|
The top 50 pharmaceutical companies occupies 70.3% of the total prescriptions
According to market fluctuation of pharmaceutical products benefited by the National Health Insurance for the past 5 years(2010-2014), the top 50 pharmaceutical companies have shown high concentration with 70.3% of th...
Hanmi started to develop the first generic of Nexavar, a targeted anti-cancer drugHanmi Pharm has begun to develop the first generic of Nexavar(generic name: sorafenib), a liver cancer treatment.
According to the Ministry of Food and Drug Safety on the 16th,...
|
A half of doctor have had no idea if drug price decreases after patent expiration
A survey has shown that the most effective way to prevent ‘Patent Cliff,’ a phenomenon of decreasing sales of original products after generic launches, may be just ‘to inform the expiration to the public.’ Generally, ...
